Octreotide [oktreotid]
- Terms
-
oktreotid acetát
Sandostatin
syntetický derivát somatostatinu
synteticky vyrobený somatostatin
-
Compound 201-995
Octreotide Acetate
Octreotide Acetate Salt
SAN 201-995
Sandostatin
Sandostatine
Sandoz 201-995
SM 201-995
SMS 201-995
A potent, long-acting synthetic SOMATOSTATIN octapeptide analog that inhibits secretion of GROWTH HORMONE and is used to treat hormone-secreting tumors; DIABETES MELLITUS; HYPOTENSION, ORTHOSTATIC; HYPERINSULINISM; hypergastrinemia; and small bowel fistula.
- DUI
- D015282 MeSH Browser
- CUI
- M0023526
- CAS
- L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-(2-hydroxy-1-(hydroxymethyl)propyl)-, cyclic (2-7)-disulfide, (R-(R*,R*))-
- Previous indexing
- Antineoplastic Agents (1982-1988); Somatostatin/analogs & derivatives (1982-1988)
- History note
- 89
- Public note
- 89
Allowable subheadings
- AD
- administration & dosage 61
- AE
- adverse effects 16
- AG
- agonists 0
- AA
- analogs & derivatives 13
- AN
- analysis 0
- AI
- antagonists & inhibitors 0
- BL
- blood 0
- CF
- cerebrospinal fluid 0
- CS
- chemical synthesis 0
- CH
- chemistry 4
- CL
- classification 0
- EC
- economics 0
- HI
- history 0
- IM
- immunology 0
- IP
- isolation & purification 0
- ME
- metabolism 0
- PK
- pharmacokinetics 10
- PD
- pharmacology 38
- PO
- poisoning 0
- RE
- radiation effects 0
- ST
- standards 0
- SD
- supply & distribution 0
- TU
- therapeutic use 88
- TO
- toxicity 0
- UR
- urine 0